MA46239A - Mousse pharmaceutique stable - Google Patents
Mousse pharmaceutique stableInfo
- Publication number
- MA46239A MA46239A MA046239A MA46239A MA46239A MA 46239 A MA46239 A MA 46239A MA 046239 A MA046239 A MA 046239A MA 46239 A MA46239 A MA 46239A MA 46239 A MA46239 A MA 46239A
- Authority
- MA
- Morocco
- Prior art keywords
- stable pharmaceutical
- pharmaceutical foam
- foam
- stable
- pharmaceutical
- Prior art date
Links
- 239000008255 pharmaceutical foam Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A61K9/122—Foams; Dry foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
- A61K38/014—Hydrolysed proteins; Derivatives thereof from animals from connective tissue peptides, e.g. gelatin, collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
- A61K38/363—Fibrinogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4833—Thrombin (3.4.21.5)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0028—Polypeptides; Proteins; Degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0028—Polypeptides; Proteins; Degradation products thereof
- A61L26/0042—Fibrin; Fibrinogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0028—Polypeptides; Proteins; Degradation products thereof
- A61L26/0047—Specific proteins or polypeptides not covered by groups A61L26/0033 - A61L26/0042
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0085—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/04—Materials for stopping bleeding
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Materials Engineering (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662394371P | 2016-09-14 | 2016-09-14 | |
IL247810A IL247810A0 (en) | 2016-09-14 | 2016-09-14 | Stable pharmaceutical foam |
Publications (1)
Publication Number | Publication Date |
---|---|
MA46239A true MA46239A (fr) | 2019-07-24 |
Family
ID=60022140
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA046239A MA46239A (fr) | 2016-09-14 | 2017-09-11 | Mousse pharmaceutique stable |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP3512502A1 (ko) |
JP (1) | JP7114597B2 (ko) |
KR (1) | KR102656742B1 (ko) |
CN (1) | CN109789091A (ko) |
AU (1) | AU2017328480A1 (ko) |
CA (1) | CA3036770A1 (ko) |
IL (1) | IL265252B2 (ko) |
MA (1) | MA46239A (ko) |
WO (1) | WO2018051325A1 (ko) |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2492458A (en) | 1944-12-08 | 1949-12-27 | Jr Edgar A Bering | Fibrin foam |
CH264752A (de) * | 1947-06-03 | 1949-10-31 | Hoffmann La Roche | Verfahren zur Herstellung von Trägern für Arzneimittel. |
JPS5814813B2 (ja) * | 1976-11-09 | 1983-03-22 | 味の素株式会社 | 起泡剤及びその製造法 |
US6454787B1 (en) | 1998-12-11 | 2002-09-24 | C. R. Bard, Inc. | Collagen hemostatic foam |
ES2242631T3 (es) | 1999-07-21 | 2005-11-16 | Imedex Biomateriaux | Espuma de una proteina adhesiva para usos quirurgicos y/o terapeuticos. |
EP1257304B1 (en) | 2000-02-25 | 2004-02-04 | David Sierra | Foam-forming wound dressing |
CN1250605C (zh) * | 2001-03-26 | 2006-04-12 | 拜尔公司 | 具有显著剪切变稀行为的聚碳酸酯 |
US8741335B2 (en) | 2002-06-14 | 2014-06-03 | Hemcon Medical Technologies, Inc. | Hemostatic compositions, assemblies, systems, and methods employing particulate hemostatic agents formed from hydrophilic polymer foam such as Chitosan |
US6749842B2 (en) * | 2002-01-24 | 2004-06-15 | Midwest Grain Products | Liquid foam builder containing hydrolyzed grain protein |
US8202549B2 (en) | 2007-08-14 | 2012-06-19 | The Regents Of The University Of California | Mesocellular oxide foams as hemostatic compositions and methods of use |
CA2710798A1 (en) * | 2007-12-28 | 2009-07-09 | Kuros Biosurgery Ag | Pdgf fusion proteins incorporated into fibrin foams |
EP2259803B2 (en) * | 2008-02-29 | 2019-03-13 | Ferrosan Medical Devices A/S | Device for promotion of hemostasis and/or wound healing |
EP2252335B1 (en) * | 2008-03-03 | 2013-04-24 | Omrix Biopharmaceuticals Ltd. | A gelatin sponge comprising an active ingredient, its preparation and use |
US8512740B2 (en) | 2008-03-26 | 2013-08-20 | Baxter International Inc. | Fibrin foam and process for making |
US8753670B2 (en) | 2008-03-26 | 2014-06-17 | Baxter International Inc. | Fibrin foam and process |
US20110036133A1 (en) * | 2008-04-18 | 2011-02-17 | N. V. Organon | Purification of protein hydrolysate and the result and products |
US20100021527A1 (en) | 2008-07-25 | 2010-01-28 | Chunlin Yang | Collagen-related peptides and uses thereof and hemostatic foam substrates |
US8778883B2 (en) | 2009-11-13 | 2014-07-15 | Industrial Technology Research Institute | Foamy biomaterial for biological tissue repair |
RU2013155713A (ru) | 2011-07-06 | 2015-08-20 | Профибрикс Бв | Составы для лечения ран |
US8680240B1 (en) | 2012-11-01 | 2014-03-25 | George David Falus | Tissue sealant for use in non-compressible hemorrhage |
EP2928511B1 (en) | 2012-12-07 | 2020-04-22 | Baxter International Inc. | Hemostatic foam |
CN105543315A (zh) * | 2015-12-16 | 2016-05-04 | 陕西科技大学 | 胶原蛋白类发泡剂、其复配改性发泡剂以及二者的制备方法 |
-
2017
- 2017-09-11 EP EP17780529.8A patent/EP3512502A1/en not_active Withdrawn
- 2017-09-11 AU AU2017328480A patent/AU2017328480A1/en not_active Abandoned
- 2017-09-11 WO PCT/IL2017/000007 patent/WO2018051325A1/en unknown
- 2017-09-11 CN CN201780056569.1A patent/CN109789091A/zh active Pending
- 2017-09-11 CA CA3036770A patent/CA3036770A1/en not_active Abandoned
- 2017-09-11 KR KR1020197010499A patent/KR102656742B1/ko active IP Right Grant
- 2017-09-11 MA MA046239A patent/MA46239A/fr unknown
- 2017-09-11 JP JP2019536003A patent/JP7114597B2/ja active Active
- 2017-09-11 IL IL265252A patent/IL265252B2/en unknown
Also Published As
Publication number | Publication date |
---|---|
KR102656742B1 (ko) | 2024-04-15 |
CA3036770A1 (en) | 2018-03-22 |
JP2019526646A (ja) | 2019-09-19 |
IL265252B2 (en) | 2023-11-01 |
JP7114597B2 (ja) | 2022-08-08 |
IL265252B1 (en) | 2023-07-01 |
KR20190054110A (ko) | 2019-05-21 |
CN109789091A (zh) | 2019-05-21 |
AU2017328480A1 (en) | 2019-03-14 |
IL265252A (en) | 2019-05-30 |
EP3512502A1 (en) | 2019-07-24 |
WO2018051325A1 (en) | 2018-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3479819T5 (da) | Stabilt væskeformigt farmaceutisk præparat | |
DK3529248T3 (da) | Farmaceutiske sammensætninger | |
DK3328880T3 (da) | Terapeutiske midler | |
MA50541A (fr) | Formulations pharmaceutiques | |
MA46334A (fr) | Composition pharmaceutique liquide | |
DK3634377T3 (da) | Farmaceutisk formulering | |
DK3529240T3 (da) | Farmaceutiske forbindelser | |
MA42303A (fr) | Formulations pharmaceutiques | |
MA43705A (fr) | Formulation pharmaceutique | |
MA43375A (fr) | Mousse minérale ultra-légère | |
MA46867A (fr) | Formulations pharmaceutiques | |
DK3463345T3 (da) | Farmaceutiske kombinationer | |
DK3199161T3 (da) | Farmaceutisk præparat | |
MA44987A (fr) | Formulations de médicaments améliorées | |
DK3525897T3 (da) | Spilsystem | |
DK3679010T3 (da) | Kulsyre-additionsprodukter | |
MA42964A (fr) | Préparation pharmaceutique anti-vieillissement | |
MA47516A (fr) | Composition pharmaceutique | |
IL266537A (en) | pharmaceutical preparation | |
MA49822A (fr) | Combinaison pharmaceutique comprenant du ponesimod | |
DK3280447T3 (da) | Farmaceutiske formuleringer | |
ZA201807851B (en) | Pharmaceutical formulation | |
DK3601277T3 (da) | Farmaceutisk formulering | |
CL2016002705A1 (es) | Formulación agroquímica | |
SE1651557A1 (sv) | Medical support |